Alessio Gerussi
banner
aleger87.bsky.social
Alessio Gerussi
@aleger87.bsky.social
Hepatologist and Assistant Professor at University of Milano-Bicocca. Interested in autoimmune liver disease and AI.
Reposted by Alessio Gerussi
The prognosis of liver disease depends on the extent of fibrosis, which is usually staged with the use of liver biopsy. The limitations of biopsy have led to the development of noninvasive tests, which the authors review. Learn more: nej.md/4hwZMgj

#MedSky #GastroSky
October 29, 2025 at 10:00 PM
Reposted by Alessio Gerussi
🔥 Looking for automated segmentation of liver histopathology? Don‘t look further.

Hotspot Model got you covered.

Happy to have contributed.

Great work @aleger87.bsky.social and team!

rdcu.be/ew7qh
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model
npj Digital Medicine - Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model
rdcu.be
July 22, 2025 at 6:04 AM
🔥 HOTSPoT sets a new benchmark in liver pathology: open-source, accurate, and externally validated tool for portal tract segmentation. A brilliant team effort led by Giorgio Cazzaniga — whose vision and drive made it possible 👏
rdcu.be/ew7qh #AI #Digitalpathology
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model
npj Digital Medicine - Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model
rdcu.be
July 21, 2025 at 7:08 AM
Great visit to EKFZ Digital Health Institute! Gave a talk at Jakob Kather’s lab, had great 1:1s with team members, and visited our PhD student Elisa Merelli, who's spending part of her PhD here💡🔬 #DigitalHealth #AI #Research
@jnkt.bsky.social @janclusmann.bsky.social
June 10, 2025 at 3:32 PM
Reposted by Alessio Gerussi
This article analyzes how nonexperts perceive AI-generated medical advice, finding that it is often rated as accurate as — or better than — doctor responses, raising concerns about overreliance and potential harm from incorrect guidance. Full article: nejm.ai/43xKDG0

#AI #MedSky #MLSky
People Overtrust AI-Generated Medical Advice despite Low Accuracy
This article presents a comprehensive analysis of how artificial intelligence (AI)–generated medical responses are perceived and evaluated by nonexperts. We conducted a study in which a total of 30...
nejm.ai
May 22, 2025 at 1:18 PM
Reposted by Alessio Gerussi
In the SELECT-GCA phase 3 trial involving patients with giant-cell arteritis, the oral Janus kinase inhibitor upadacitinib (15 mg) significantly improved remission of disease, with less glucocorticoid use. Full trial results: nej.md/3XBdkia

#MedSky
April 3, 2025 at 3:02 PM
Reposted by Alessio Gerussi
Happy to share our latest paper in @ai.nejm.org, led by Isabella Wiest: "Deidentifying Medical Documents with Local, Privacy-Preserving Large Language Models: The LLM-Anonymizer" ai.nejm.org/doi/full/10....
You can use our open source tool with local LLMs to robustly de-identify medical documents.
March 27, 2025 at 6:32 PM
Reposted by Alessio Gerussi
Il 18enne italiano è arrivato quarto in Australia, diventando il secondo pilota più giovane di sempre a fare punti dopo Max Verstappen
ilpost.link/Scna5U9zdB
Il grande esordio di Andrea Kimi Antonelli in Formula 1 - Il Post
Il 18enne italiano è arrivato quarto in Australia, diventando il secondo pilota più giovane di sempre a fare punti dopo Max Verstappen
ilpost.link
March 16, 2025 at 10:43 AM